membranous nephropathy

You have accessRestricted Access
Multi-Autoantibody Signature and Clinical Outcome in Membranous Nephropathy
Gian Marco Ghiggeri, Barbara Seitz-Polski, Joana Justino, Christelle Zaghrini, Christine Payré, Vesna Brglez, Guillaume Dolla, Alberto Sinico, Francesco Scolari, Augusto Vaglio, Marco Prunotto, Giovanni Candiano, Antonella Radice, Maurizio Bruschi, Gérard Lambeau and on behalf of The Italian Study Group for Membranous Nephropathy

CJASN December 2020, 15 (12) 1762-1776; DOI: https://doi.org/10.2215/CJN.02500220

Add to Selected Citations
Open Access
GWAS-Based Discoveries in IgA Nephropathy, Membranous Nephropathy, and Steroid Sensitive Nephrotic Syndrome
Elena Sanchez-Rodriguez, Christopher T. Southard and Krzysztof Kiryluk

CJASN July 2020, CJN.14031119; DOI: https://doi.org/10.2215/CJN.14031119

Add to Selected Citations
Open Access
Screening for Cancer in Patients with Glomerular Diseases
Emmanuelle Plaisier and Pierre Ronco

CJASN June 2020, 15 (6) 886-888; DOI: https://doi.org/10.2215/CJN.09000819

Add to Selected Citations
Open Access
The Impact of Household Income on Kidney Care
Stephen Weed

CJASN March 2020, 15 (3) 299-300; DOI: https://doi.org/10.2215/CJN.00180120

Add to Selected Citations
You have accessRestricted Access
NSAIDs and Nephrotic Syndrome
Evangelina Mérida and Manuel Praga

CJASN September 2019, 14 (9) 1280-1282; DOI: https://doi.org/10.2215/CJN.08090719

Add to Selected Citations
You have accessRestricted Access
Does Epitope Spreading Influence Responsiveness to Rituximab in PLA2R-Associated Membranous Nephropathy?
David J. Salant

CJASN August 2019, 14 (8) 1122-1124; DOI: https://doi.org/10.2215/CJN.07300619

Add to Selected Citations
You have accessRestricted Access
High-Dose Rituximab and Early Remission in PLA2R1-Related Membranous Nephropathy
Barbara Seitz-Polski, Karine Dahan, Hanna Debiec, Alexandra Rousseau, Marine Andreani, Christelle Zaghrini, Michel Ticchioni, Alessandra Rosenthal, Sylvia Benzaken, Ghislaine Bernard, Gérard Lambeau, Pierre Ronco and Vincent L.M. Esnault

CJASN August 2019, 14 (8) 1173-1182; DOI: https://doi.org/10.2215/CJN.11791018

Add to Selected Citations
You have accessRestricted Access
Complications of Immunosuppression in Glomerular Disease
J. Ashley Jefferson

CJASN August 2018, 13 (8) 1264-1275; DOI: https://doi.org/10.2215/CJN.01920218

Add to Selected Citations
You have accessRestricted Access
Evolving Epidemiology of Pediatric Glomerular Disease
Michelle N. Rheault and Scott E. Wenderfer

CJASN July 2018, 13 (7) 977-978; DOI: https://doi.org/10.2215/CJN.06220518

Add to Selected Citations
You have accessRestricted Access
Management of Membranous Nephropathy in the PLA₂R Era
Andrew S. Bomback

CJASN May 2018, 13 (5) 784-786; DOI: https://doi.org/10.2215/CJN.12461117

Add to Selected Citations

Main menu

User menu

Search

membranous nephropathy

Pages

Articles

Information for Authors

About

Journal Information

More Information